| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159015C Use of silbene glycoside in treating dementia |
| 07/28/2004 | CN1159014C Use of 4 alpha-methyl-17 alpha-ethyle-estrane derivative for treatment of atherosclerosis |
| 07/28/2004 | CN1159013C Use of combination of vitamins for the treatment of pruritus and relating to itching and/or non-infective inflammatory disorders |
| 07/28/2004 | CN1159012C Pharmaceutical composition of combination of piperidinoalkanol-decongestant |
| 07/28/2004 | CN1159011C 苦参碱阴道凝胶 Matrine vaginal gel |
| 07/28/2004 | CN1159010C Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 07/28/2004 | CN1159009C Pharmaceutical use of benzoci acid derivatives |
| 07/28/2004 | CN1159008C Concentrated granular medicine for treating baby cold and preparation preocess thereof |
| 07/28/2004 | CN1159007C Benzimidazole compounds |
| 07/28/2004 | CN1159006C Application of bilirubin and its derivative as preparation of resisting influenza viurs A1 type |
| 07/28/2004 | CN1159005C Inhibiting free radical compound resulting in cancer cell transfer |
| 07/28/2004 | CN1159004C Swallowable tablets with high content of N-acetylcysteine |
| 07/28/2004 | CN1159003C Locally-used weight reducing face-care compsns. |
| 07/28/2004 | CN1159000C Buccal delivery system |
| 07/28/2004 | CN1158999C Controlled release oral tablet having a unitary core |
| 07/28/2004 | CN1158997C A process for the preparation of suspensions of drug particles for inhalation delivery |
| 07/28/2004 | CN1158996C Medicinal aerosol formulations |
| 07/28/2004 | CN1158995C Fluorometholone suspension eye drops |
| 07/28/2004 | CN1158994C Topcial suspension formulations containing cirporfloxacin and dexa methasone |
| 07/28/2004 | CN1158992C Microcrystalline cellulose/alginate pharmaceutical suspensions |
| 07/27/2004 | US6768026 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis |
| 07/27/2004 | US6768019 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1h-naphthalene-2 -one oxime |
| 07/27/2004 | US6768012 Process for the preparation of paclitaxel |
| 07/27/2004 | US6768011 Antidepressants; reacting 3-(4-fluoro-), 6-cyanoisobenzofuranwith alkylation agent |
| 07/27/2004 | US6767926 Pretreatment with alpha, beta-unsaturated aryl sulfone as cytoprotectant; side effect reduction during cancer treatment; mitotic phase cell cycle inhibitor or topoisomerase inhibitors |
| 07/27/2004 | US6767925 Sprayable analgesic composition and method of use |
| 07/27/2004 | US6767924 Method of using hydroxycarboxylic acids or related compounds for treating skin changes associated with intrinsic and extrinsic aging |
| 07/27/2004 | US6767921 Polymorphic forms of fasidotril, their methods of preparation and pharmaceutical compositions comprising them |
| 07/27/2004 | US6767920 Administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of 3 or 7 or 3 and 7 thia-prostanoic acid, ester, amide, phosphonate or other derivatives |
| 07/27/2004 | US6767919 High specificity anticancer agents |
| 07/27/2004 | US6767918 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | US6767916 Chalcone coumarins |
| 07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
| 07/27/2004 | US6767912 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/27/2004 | US6767911 Fungicidal active compound combinations |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767908 Treatment of cytokine mediated diseases such as arthritis. |
| 07/27/2004 | US6767907 For therapy of psychic and neurologic disorders |
| 07/27/2004 | US6767906 Inhibit p34cdc2/cyclin bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example chemotherapy of tumours or osteoporosis. |
| 07/27/2004 | US6767905 Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
| 07/27/2004 | US6767904 Steroid derived antibiotics |
| 07/27/2004 | US6767903 New7α, 17α-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/27/2004 | US6767902 Androgen as a male contraceptive and non-contraceptive androgen replacement |
| 07/27/2004 | US6767901 Ciclesonide contained pharmaceutical composition for application to mucosa |
| 07/27/2004 | US6767900 Phosphonate nucleotide compound |
| 07/27/2004 | US6767899 Composition and method for treatment of conditions having an inflammatory component |
| 07/27/2004 | US6767898 Administering glucose |
| 07/27/2004 | US6767888 Treating cerebral ischemia by systemically administering hedgehog polypeptide comprising amino acid sequence that binds to naturally occurring patched receptor and promotes hedgehog signal transduction; encoded by specified nucleotide sequence |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
| 07/27/2004 | US6767565 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 07/27/2004 | US6767563 Mixture of chrysin, diindolomethane, resveratrol, quercitrin, plant extracts and phosphatidyl choline; food |
| 07/27/2004 | US6767561 Plant extracts as antiproliferative, viricides and antiparasitic agents |
| 07/27/2004 | US6767557 Taste masked pharmaceutical compositions |
| 07/27/2004 | US6767556 Hypotensive agents |
| 07/27/2004 | US6767552 Adhesive treatment for oral fungal infection |
| 07/27/2004 | US6767549 Ionic polymers as anti-infective agents |
| 07/27/2004 | US6767540 Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease |
| 07/27/2004 | US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 07/27/2004 | US6767531 High dose radionuclide complexes for bone marrow suppression |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2358395C Extended release formulations of erythromycin derivatives |
| 07/27/2004 | CA2331261C 2"-deoxy hygromycin derivatives |
| 07/27/2004 | CA2320233C Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 07/27/2004 | CA2251197C The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders |
| 07/27/2004 | CA2219911C Combinations for the treatment of parkinsonism containing selective nmda antagonists |
| 07/27/2004 | CA2118512C Agents for treating substance abuse disorders |
| 07/27/2004 | CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/27/2004 | CA2103072C Pleuromutilin derivatives |
| 07/24/2004 | WO2003059904A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 07/24/2004 | CA2428744A1 Inhibition of lysozyme in treating sepsis-induced myocardial dysfunction |
| 07/22/2004 | WO2004061408A2 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 07/22/2004 | WO2004061115A1 PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF |
| 07/22/2004 | WO2004061090A1 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same |
| 07/22/2004 | WO2004061084A2 Modulation of protein functionalities |
| 07/22/2004 | WO2004060907A2 Compounds that bind p2y2 or p2y1 receptors |
| 07/22/2004 | WO2004060903A2 Aerosolizable pharmaceutical formulation for fungal infection therapy |
| 07/22/2004 | WO2004060888A1 Novel cb 1 receptor inverse agonists |
| 07/22/2004 | WO2004060882A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004060878A2 Inhibitors of phosphatases |
| 07/22/2004 | WO2004060874A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
| 07/22/2004 | WO2004060873A1 Novel 5-hydroxyindole-3-carboxylate derivatives |
| 07/22/2004 | WO2004060870A1 Novel cb 1 receptour inverse agonists |
| 07/22/2004 | WO2004060798A1 Nanocarbon solubilizer, method for purifying same, and method for producing high-purity nanocarbon |
| 07/22/2004 | WO2004060490A1 Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent |
| 07/22/2004 | WO2004060489A2 Treatment of chronic heart failure |
| 07/22/2004 | WO2004060488A1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/22/2004 | WO2004060487A2 Composition for the treatment of hiv or aids |
| 07/22/2004 | WO2004060409A1 Enhanced scintigraphic imaging agents for imaging of infection and inflammation |
| 07/22/2004 | WO2004060401A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/22/2004 | WO2004060400A1 Antipsychotic molecular-targeting epithelial growth factor receptor |
| 07/22/2004 | WO2004060399A1 Body weight gain inhibitor |
| 07/22/2004 | WO2004060398A1 Connexin 26 inhibitors and cancer metastasis inhibitors |
| 07/22/2004 | WO2004060394A1 Wound and skin care products |
| 07/22/2004 | WO2004060390A2 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 07/22/2004 | WO2004060380A1 Rhamnan sulphate composition for treatment of endothelial dysfunction |
| 07/22/2004 | WO2004060379A2 Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications |